Insights

The CSL (ASX:CSL) share price is now well above $300. Is it on a roll?

CSL shares have been pushing higher recently…
The post The CSL (ASX:CSL) share price is now well above $300. Is it on a roll? appeared first on The Motley Fool Australia. –

The CSL Limited (ASX: CSL) share price was on form again last week.

The biotherapeutics giant’s shares outperformed the market and rose 3% to end the period at $314.48.

This is the highest level the CSL share price has closed at in 2021.

Is the CSL share price on a roll?

The CSL share price certainly appears to be on a roll. This latest gain means its shares are now up 10% since this time last month. They are also up an impressive 30% since hitting a 52-week low of $242.00 in March.

The good news is that one leading broker still believes the company’s shares could rise a touch further from here.

A recent note out of Morgans reveals that its analysts have an add rating and $324.40 price target on its shares.

Why is the broker positive on CSL?

While Morgans acknowledges that FY 2022 will not be an easy year and CSL is likely to report a decline in its earnings, the broker believes the headwinds the company is facing are short term and not structural.

It commented: “FY22 guidance is targeting cc NPAT between US$2,150-2,250bn (-9% to -5%) on revenue growth between 2-5%, with management flagging a “transitional year”, core plasma products “robust”, but margins contracting on increased costs, and Seqirus strength ongoing.”

“Our FY22-24 earnings forecasts decrease up to 6.3%, mainly on lowered GM (350bp) and increased operating expenditures across the Behring division,” it added.

Morgans concluded: “We view CSL as a core holding and best positioned among its peers to meet growing patient demand, but the near term remains challenged, with timing uncertainty around a full recovery in plasma collections and increasing costs.”

The post The CSL (ASX:CSL) share price is now well above $300. Is it on a roll? appeared first on The Motley Fool Australia.

Should you invest $1,000 in CSL right now?

Before you consider CSL, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

2 buy-rated blue chip ASX shares to boost your portfolio

What happened to the CSL (ASX:CSL) share price in October?

Own biotech shares? These were the best performers during October

CSL (ASX:CSL) share price lifts 2% amid US border patrol battle

Own CSL shares? Here’s how the company actually makes money

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!